Guidelines

International Guidelines

ATOPIC DERMATITIS

Wollenberg et al. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy. JEADV 2022. Wollenberg et al. European guideline (EuroGuiDerm) on atopic eczema – part II: non-systemic treatments and treatment recommendations for special AE patient populations. JEADV 2022 Wollenberg et al. First update of the living European guideline (EuroGuiDerm) on atopic eczema. JEADV 2023 Wollenberg et al: European Guideline (EuroGuiDerm) on atopic eczema: Living update JEADV 2025

PSORIASIS

Nast et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations. JEADV 2020.

 

Nast et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations. JEADV 2021

ACTINIC KERATOSIS

Kandolf et al. European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes). JEADV 2024
 
Eisen D et al. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021
 

National Guidelines

DENMARK

Medicinrådets behandlingsvejledning vedr. Atopisk Eksem

Medicinrådets behandlingsvejledning vedr. Psoriasis med og uden ledgener

Dansk Dermatologisk Selsksabs Retningslinjer (DDS)

Dansk Melanom Gruppe Retningslinjer (DMG)

Magistrelle lægemidler (Glostrup Apotek)

NORWAY

Veiledende anbefalinger for bruk av biologiske lekemidler og JAK-hemmere ved atopisk eksem

Veiledende anbefalinger for systemisk behandling av psoriasis vulgaris

TNF BIO (Nord og Sør-Øst)

TNF-BIO (Vest og Midt)

SWEDEN

Läkemedelsverkets behandlingsrekommendationer

Läkemedelsverkets behandlingsrekommendation – atopisk dermatit

SSDVs rekommendationer

SSDVs rekommendationer för systemisk behandling av psoriasis

You are now leaving the page

Dear visitor,

If you follow this link, you will leave the ciclopoli.de website.

The terms of use and data protection guidelines of the target site then apply.

Stay
Exit ❯

The information provided on this website is intended for health professionals trained to prescribe and dispense medications, so they require specific scientific knowledge and training to interpret it correctly.

I am a healthcare professional